-
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction
-
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms
-
Comprehensive care for schizophrenia: smart choices by clinicians can make a huge difference, even when resources are limited
-
Quality of Life After Psychosis: Surviving Schizophrenia and Making a Full Emotional Recovery
-
Taking care of psychotic disorders globally, beyond clinical management
-
Towards an integrative and personalized care across the stages of schizophrenia spectrum disorders
-
An excitement building in the development of psychological treatments for schizophrenia
-
Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan
-
Delusion of Jinn Possession in a Young Man With Schizophrenia: Case Report and Impact of Including a Religious Leader in Patient Care
-
The new German evidence‐ and consensus‐based schizophrenia guideline
-
Real-World Effectiveness and Safety of Ofatumumab: Analysis of B Cell Depletion, Comorbidities and Ethnicity in a Spanish Cohort
-
Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis
-
Does having bad epilepsy make you a good surgical candidate? A number needed to treat analysis
-
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results
-
Real-World Experience of Sustained-Release Fampridine in Chinese Patients With Multiple Sclerosis: A Case Series on Walking Impairment and Fatigue
-
Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying
-
The problem of recognition of clinical high‐risk states is hampering the prevention of schizophrenia
-
Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review
-
Effectiveness of adjunctive low‐dose clobazam in adults with focal drug‐resistant epilepsy and incomplete response to cenobamate: A real‐world study
-
Aerobic Exercise for Cognitive and Functional Enhancement in Schizophrenia: Evidence, Mechanisms, and Practical Recommendations
-
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
-
Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia
-
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program
-
Effectiveness of Electroconvulsive Therapy in the Remission of Malignant Catatonia Associated With Schizophrenia: A Case Report
